Explorer
Advertisement
Sii
News
Govt Panel Recommends Granting Emergency Approval To Covovax For 12-17 Age Group
Health
Serum Institute Seeks EUA For Its Covovax Vaccine For 12-17 Years Age Group
Health
Govt Panel Recommends Regular Market Approval For Covishield And Covaxin
News
SII Gets DCGI Nod To Manufacture Drug Substance, Test It For Developing Jab Against Omicron
Business
Covid Vaccine For Children Aged 3 Plus To Be Launched By June 2022: SII CEO Adar Poonawala
India
SII Executive Director Dr Suresh Jadhav, 72, Passes Away In Pune
Health
SII To Cut Covishield's Production By 50%, CEO Adar Poonawalla Explains
India
Covid Booster Shots In India? SII Seeks DCGI's Approval For Covishield Booster Dose
India
'Total Chaos': SII CEO Adar Poonawalla Comments On UK Travel Restrictions
India
TIME's 100 Most Influential People: Taliban's Mullah Baradar, PM Modi, Mamata Find Place In Elite List
Business
Adar Poonawalla’s Serum Institute Takes 50% Stake In Drug Vial Maker SCHOTT Kaisha
India
Hopeful Of Launching Covovax For Children In Early 2022, For Adults In Oct This Year: Adar Poonawalla
Videos
India
SII Corona Vaccine to reach four cities of Madhya Pradesh
Short Videos
Advertisement
Advertisement
Advertisement
Top Headlines
India
Election 2024
India
India
Advertisement